685 related articles for article (PubMed ID: 16760923)
1. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
Achat-Mendes C; Anderson KL; Itzhak Y
Neuropsychopharmacology; 2007 Mar; 32(3):531-41. PubMed ID: 16760923
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice.
Achat-Mendes C; Ali SF; Itzhak Y
Neuropsychopharmacology; 2005 Jun; 30(6):1128-37. PubMed ID: 15688084
[TBL] [Abstract][Full Text] [Related]
3. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
Itzhak Y; Martin JL; Ali SF
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
Ramkissoon A; Wells PG
Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
6. Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.
Fukami G; Hashimoto K; Koike K; Okamura N; Shimizu E; Iyo M
Brain Res; 2004 Jul; 1016(1):90-5. PubMed ID: 15234256
[TBL] [Abstract][Full Text] [Related]
7. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.
Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A
Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348
[TBL] [Abstract][Full Text] [Related]
8. Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.
Melega WP; Jorgensen MJ; Laćan G; Way BM; Pham J; Morton G; Cho AK; Fairbanks LA
Neuropsychopharmacology; 2008 May; 33(6):1441-52. PubMed ID: 17625500
[TBL] [Abstract][Full Text] [Related]
9. Protective and restorative effects of the traditional Chinese medicine Jitai tablet against methamphetamine-induced dopaminergic neurotoxicity.
Xu S; Tu S; Gao J; Liu J; Guo Z; Zhang J; Liu X; Liang J; Huang Y; Han M
BMC Complement Altern Med; 2018 Feb; 18(1):76. PubMed ID: 29475448
[TBL] [Abstract][Full Text] [Related]
10. Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain.
Yu J; Wang J; Cadet JL; Angulo JA
Brain Res; 2004 May; 1007(1-2):124-31. PubMed ID: 15064143
[TBL] [Abstract][Full Text] [Related]
11. Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity.
Thomas DM; Francescutti-Verbeem DM; Kuhn DM
J Neurochem; 2009 Jun; 109(6):1745-55. PubMed ID: 19457119
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D1/D5 receptors in the dorsal hippocampus are required for the acquisition and expression of a single trial cocaine-associated memory.
Kramar CP; Barbano MF; Medina JH
Neurobiol Learn Mem; 2014 Dec; 116():172-80. PubMed ID: 25452086
[TBL] [Abstract][Full Text] [Related]
13. Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation.
Mateo Y; Lack CM; Morgan D; Roberts DC; Jones SR
Neuropsychopharmacology; 2005 Aug; 30(8):1455-63. PubMed ID: 15702135
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse.
Anderson KL; Itzhak Y
Ann N Y Acad Sci; 2006 Aug; 1074():225-33. PubMed ID: 17105919
[TBL] [Abstract][Full Text] [Related]
15. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors.
Xu W; Zhu JP; Angulo JA
Synapse; 2005 Nov; 58(2):110-21. PubMed ID: 16088948
[TBL] [Abstract][Full Text] [Related]
16. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
17. The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice.
Liddie S; Anderson KL; Paz A; Itzhak Y
J Psychopharmacol; 2012 Oct; 26(10):1375-82. PubMed ID: 22596207
[TBL] [Abstract][Full Text] [Related]
18. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors.
Houchi H; Babovic D; Pierrefiche O; Ledent C; Daoust M; Naassila M
Neuropsychopharmacology; 2005 Feb; 30(2):339-49. PubMed ID: 15383833
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
Albers DS; Sonsalla PK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
[TBL] [Abstract][Full Text] [Related]
20. Repeated administration of dopaminergic agents in the nucleus accumbens and morphine-induced place preference.
Zarrindast MR; Azami BN; Rostami P; Rezayof A
Behav Brain Res; 2006 May; 169(2):248-55. PubMed ID: 16472879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
